No photo available
Sep 24, 2019 — Limited time opportunity at attractive valuation.
Company is the worldwide patent-holder of the world's only organoleptically-comparable ultra-low calorie and carbohydrate flour displacement product. The Company can produce any flour based product such as bread and pasta with 68% to 84% less available calories and carbs, that look, taste and perform according to double blind tests the same as conventional flour products.
Why is this important? Over 1/3 of the world's population is overweight and/or diabetic and is a severe health issue for nations as well as individuals. There are many diet sweeteners but no product for savory flour-based products. Studies show 3.2x more overfat and diabetic individuals would prefer a savory diet product over a sweet one.
Presently working with major multinational food companies to develop over 200 product variants including gluten-free, organic, non-GMO and all-natural. Goal is to establish the products as the world's leading savory food calorie and carbohydrate reduction ingredient. The Company is in a position to achieve considerable market penetration into the multi-trillion dollar world flour-based product market.
Incredible opportunity to invest in providing a real solution to the growing health issues surrounding an overweight and diabetic population that is growing annually worldwide. In the US alone, each overfat and diabetic individual spends an average of nearly $3,000/year on flour-based products with 100% calories and carbs. Multiply that by over 200 million people and the result is a market of $600 Billion per year.
The Company is seeking investment of a minimum of $100k to a maximum of $600k at a post-fully-funded valuation of under $3 million. First $100k (must be funded by Oct. 18th) will be used to meet the balance of expenses for the International Food Expo being held in Paris, France Dec 3-5 2019. 30,000 industry professionals attend this Expo annually. The Company is the only exhibitor that will be stationed at both hall entrances handing out 43,000 low cal/carb buns in taste comparison with the control version. Other funding will be used to introduce the product to market by utilizing a couple of medium-sized bakeries in N. America and allowing the accretion of basal sales figures while also leveraging relationships with multi-nationals and major ingredient distributors cultivated at the Paris Expo.
Only available to accredited investors through the Company's Offering Memorandum. Minimum investment US$15,000.
Learn More About This Listing
Sign up for a free basic membership to start buying and selling. Learn about our membership plans.